Advertisement
About Helsinn Healthcare
Helsinn is a privately owned pharmaceutical group with headquarters inSwitzerland. Helsinn's core business is the licensing of pharmaceuticals intherapeutic areas (oncology, cancer supportive care, pain and inflammation,gastrointestinal).
Advertisement
The company's business strategy is to in-license early-stage new chemicalentities and to complete their development from the performance ofpre-clinical/clinical studies and CMC development to the attainment of marketapprovals in strategic markets (U.S. and Europe). Helsinn's products areeventually out-licensed to its worldwide consolidated network of partners fordistribution. Helsinn's key products in the US are Aloxi(R) (palonosetron)distributed by MGI Pharma and Gelclair(R) distributed by EKR TherapeuticsInc., US. The active pharmaceutical ingredients and the drug products aremanufactured at Helsinn's cGMP facilities and supplied worldwide to itscustomers. Helsinn's chemical business focuses on the pharmaceutical chemicalprocess development and manufacturing of advanced intermediates, ActivePharmaceutical Ingredients (APIs) and High Potency Active Ingredients (HPAIs)for both the Helsinn group and its outsourcing partners. For more informationabout Helsinn, please visit http://www.helsinn.comHelsinn Healthcare Contact: Alessandro Bossi, D.V.M. Director, Business Development Phone: +41-91-985-21-21 E-Mail: [email protected]
SOURCE Helsinn Healthcare SA
